|
PDIA3P expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.81719092498633E-12 |
| Normal-vs-Stage2 |
1.64139999999646E-05 |
| Normal-vs-Stage3 |
2.68419952931254E-10 |
| Normal-vs-Stage4 |
4.82259999712298E-08 |
| Stage1-vs-Stage2 |
3.542400E-01 |
| Stage1-vs-Stage3 |
1.119620E-01 |
| Stage1-vs-Stage4 |
1.287400E-01 |
| Stage2-vs-Stage3 |
8.475800E-01 |
| Stage2-vs-Stage4 |
7.409200E-01 |
| Stage3-vs-Stage4 |
8.489000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.480500E-03 |
| Normal-vs-Asian |
9.428000E-02 |
| Caucasian-vs-AfricanAmerican |
1.202690E-03 |
| Caucasian-vs-Asian |
2.774400E-01 |
| AfricanAmerican-vs-Asian |
9.799200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.91988655476416E-14 |
| Normal-vs-Female |
4.18554080283684E-14 |
| Male-vs-Female |
6.560200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.399000E-03 |
| Normal-vs-Age(41-60Yrs) |
8.01581023779363E-13 |
| Normal-vs-Age(61-80Yrs) |
8.21565038222616E-15 |
| Normal-vs-Age(81-100Yrs) |
2.542200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.473800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.181200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.844800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.191000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.174000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.832000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.7922000000008E-05 |
| Normal-vs-Grade 2 |
3.11195513802431E-13 |
| Normal-vs-Grade 3 |
6.5536465143623E-12 |
| Normal-vs-Grade 4 |
1.48930000554159E-08 |
| Grade 1-vs-Grade 2 |
9.970000E-01 |
| Grade 1-vs-Grade 3 |
9.599000E-01 |
| Grade 1-vs-Grade 4 |
9.017900E-02 |
| Grade 2-vs-Grade 3 |
9.349200E-01 |
| Grade 2-vs-Grade 4 |
3.133700E-02 |
| Grade 3-vs-Grade 4 |
3.917700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.00595096089273E-12 |
| Normal-vs-ccB subtype |
1.738609256563E-12 |
| ccA subtype-vs-ccB subtype |
4.574100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71229697087938E-12 |
| Normal-vs-N1 |
2.345800E-02 |
| N0-vs-N1 |
4.231800E-01 |
|
|
